Form 4: Electromed Director Andrew Summers Acquires 3,000 Shares of Restricted Stock

Director Andrew Summers of Electromed, Inc. acquired 3,000 shares of restricted stock on December 1, 2024, according to a recent SEC filing.

Summary

• Andrew Summers, a director at Electromed, Inc., acquired 3,000 shares of restricted stock on December 1, 2024.
• These shares are scheduled to vest on June 1, 2025, unless accelerated or terminated earlier.
• The transaction was reported in a Form 4 filing with the SEC on December 3, 2024.
• Mr. Summers also indirectly owns 351,921 shares through Summers Value Fund LP and 198,569 shares through SVP Deal Fund I LP.
• He disclaims beneficial ownership of these indirectly held shares except to the extent of his pecuniary interest.

Sentiment

Score: 6

Explanation: The document is a neutral disclosure of an insider transaction. While the acquisition of shares by a director can be seen as a positive sign, it's a routine filing and doesn't indicate a significant shift in the company's outlook.

Positives

• The acquisition of restricted stock by a director could be seen as a positive sign of confidence in the company's future.

Industry Context

This filing is a routine disclosure of insider transactions and is common for publicly traded companies. It provides transparency into the ownership changes of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
• The reporting of indirect ownership through investment funds is also a common practice.
• The vesting schedule of the restricted stock is typical for executive compensation packages.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates

Keywords

Electromed, ELMD, Andrew Summers, restricted stock, SEC Form 4, insider trading, beneficial ownership, Summers Value Fund LP, SVP Deal Fund I LP